Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Geron Corp (GERN)
NASDAQ:GERN
Geron (GERN) Stock Price & Analysis
1,556 Followers
GERN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.18 - $3.84
Previous Close$2.14
Volume4.73M
Average Volume (3M)9.17M
Market Cap
$1.13B
Enterprise Value$971.67M
Total Cash (Recent Filing)$172.75M
Total Debt (Recent Filing)$55.75M
Price to Earnings (P/E)-5.8
Beta0.77
Next Earnings
May 08, 2023EPS Estimate
-$0.1Last Dividend Ex-Date
Jul 22, 2014Dividend YieldN/A
Share Statistics
EPS (TTM)-0.37
Shares Outstanding508,722,486
10 Day Avg. Volume6,962,158
30 Day Avg. Volume9,174,539
Standard Deviation0.23
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)14.82
Price to Sales (P/S)1852.23
Price to Cash Flow (P/CF)41.10
P/FCF Ratio-9.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.63K
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-7.24
Forecast
1Y Price Target
$5.00Price Target Upside130.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Geron News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GERN FAQ
What was Geron Corp’s price range in the past 12 months?
Geron Corp lowest stock price was $1.18 and its highest was $3.84 in the past 12 months.
What is Geron Corp’s market cap?
Currently, no data Available
When is Geron Corp’s upcoming earnings report date?
Geron Corp’s upcoming earnings report date is May 08, 2023 which is in 37 days.
How were Geron Corp’s earnings last quarter?
Geron Corp released its earnings results on Mar 16, 2023. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.123 by $0.023.
Is Geron Corp overvalued?
According to Wall Street analysts Geron Corp’s price is currently Undervalued.
Does Geron Corp pay dividends?
Geron Corp pays a Notavailable dividend of $0.15 which represents an annual dividend yield of N/A. See more information on Geron Corp dividends here
What is Geron Corp’s EPS estimate?
Geron Corp’s EPS estimate is -$0.1.
How many shares outstanding does Geron Corp have?
Geron Corp has 508,722,470 shares outstanding.
What happened to Geron Corp’s price movement after its last earnings report?
Geron Corp reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.123. Following the earnings report the stock price went down -4.528%.
Which hedge fund is a major shareholder of Geron Corp?
Among the largest hedge funds holding Geron Corp’s share is RA Capital Management. It holds Geron Corp’s shares valued at 31M.
---
Geron Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.00 (130.41% Upside)
$5.00 (130.41% Upside)
Blogger Sentiment
Bullish
GERN Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 18.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $38.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.7%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
74.21%
12-Months-Change
Fundamentals
Return on Equity
-137.49%
Trailing 12-Months
Asset Growth
-15.69%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Geron Corp
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.
---
Top 5 ETFs holding GERN
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold GERN. The ETFs are listed according to market value of GERN within the ETF
---
Iovance Biotherapeutics
―
Crinetics Pharmaceuticals
―
Viridian Therapeutics
―
Avid Bioservices
―
---